what percent of americans are on glp 1 New weight-loss drugs surge in popularity amid obesity surge in US, worldwide GLP-1 Survey: 37.5% of People

Modeling of the market size and penetration of these drugs varies widely, with estimates of 15 70 million patients by 2028 in different scenarios

National Telehealth Services Distance from Nocatee: Virtual only Pros: Convenient, no travel required, sometimes lower pricing Cons: No in-person assessment, provider 1,000+ miles away, minimal supervision, medication sourcing varies, no local support if issues arise Best For: Nocatee residents who absolutely cannot access local care (though BlueWater is closer than most think)

As a result, patients may feel the benefits sooner

This article explains what retatrutide is, why peptide stacking lacks any credible evidence base, and what safer, NHS-approved alternatives exist for weight management